News
Dr. Daniel Amen shares his BRIGHTMINDS approach for preventing Alzheimer's, addressing 11 risk factors including blood flow, ...
The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...
Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label ...
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...
Eating heavy meals at night can disrupt sleep quality and cognitive faculties..evening routine, brain health, Alzheimer's, ...
THEY aid us in almost every daily task and are among the most intricate tools we possess. But your hands can also provide a ...
A new study by scientists has uncovered four groups of health problems that can eventually lead to Alzheimer's disease. It is ...
The study, published March 6 in Nature Medicine, shows that the brain’s immune cells, called microglia, play a more powerful ...
The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results